68 Total results for product and free and sample content found
Scrip
By Eleanor Malone 20 Oct 2022
Advances in multiple scientific areas will mature into novel therapeutics, often tailored for the individual patient and increasingly curative, making biopharma an exciting place to be in 2020.
Pharmaprojects
24 Mar 2022
Pharmaprojects’ 2022 Report Highlights Breakthrough Trends in Pharmaceutical R&D
Topic Research & Development
Scrip
By Ian Haydock 08 Dec 2020
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things
HBW Insight
By Tom Gallen 29 Nov 2020
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.
Scrip
By Ian Haydock 29 Nov 2020
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things
Scrip
27 Nov 2020
Disappointment as Roche/Chugai antibody tocilizumab misses most endpoints.
Scrip
27 Nov 2020
Plus Updates On Mylan, Sinovac, Zydus Cadila
Scrip
By Scrip Team 27 Nov 2020
The company reiterates core values to 'follow the science' and 'put patients first' after talk of an emergency use authorization without completing Phase III trials.
27 Nov 2020
Get a deeper understanding of breast cancer clinical trials initiated since 2014 and what the trends have meant for strategies in this area, with this free whitepaper from Citeline.
No Records Found
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: